ARCHIVES

In Senate testimony, NCI director uses survival rate as measure of progress for goal to “eliminate suffering and death due to cancer.”

This article is from The Cancer Letter archive.

Vol. 31 No. 30 | July 29, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA Oncological Drugs Advisory Committee Gets New Charter, Georgetown’s Schein Is Chairman

October 13, 1978

CPRIT Sets Funding Priorities For Rare and Pediatric Cancers

November 14, 2014

Rush-Presbyterian Professor Committed Misconduct, ORI Says

October 6, 1995

Women Are Less Active After A Diagnosis of Breast Cancer

March 28, 2003

Promising Areas Of Research Listed By NCAB Subcommittee

February 12, 1982

In Brief: Sabin Leaves Frederick For So. Carolina; Georgia Worried Over Missing Out On Comprehensive Center

October 11, 1974